4. Discontinued Operations: Sale of Assets (Details - Allocation of sale price) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Jun. 30, 2020 |
Jun. 24, 2020 |
Jun. 30, 2019 |
|
| Proceeds from sale of business | $ 610,000 | $ 0 | |
| Micromed Laboratories [Member] | |||
| Customer base | $ 850,000 | ||
| Less: Funds remaining in escrow | (60,000) | ||
| Less: Services due from buyer | (100,000) | ||
| Less: Working capital adjustment | (80,000) | ||
| Proceeds from sale of business | $ 610,000 | ||
| X | ||||||||||
- Definition Disposal Group, Including Discontinued Operation, Working Capital No definition available.
|
| X | ||||||||||
- Definition Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as deferred revenue attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|